← Back to Search

Behavioral Intervention

Patient Navigation for Cancer (GUIDE Trial)

N/A
Recruiting
Led By Jason Mendoza, MD, MPH
Research Sponsored by Fred Hutchinson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients must be ≥ 18 years of age
Be older than 18 years old
Must not have
Children, adolescents, and teens under the age of 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 6 months
Awards & highlights

Summary

This trial aims to increase participation and diversity in cancer clinical trials by using a program called GUIDE. GUIDE involves a trained navigator working with potential patients to help them overcome barriers like health-related social needs and financial

Who is the study for?
This trial is for cancer patients who may face social and financial barriers to participating in clinical trials. It aims to help those with breast, gastrointestinal, or bladder cancer by providing a 'Guide' to navigate the process.
What is being tested?
The study tests a patient navigation program called GUIDE that assigns a trained navigator to assist potential participants in overcoming obstacles to join cancer clinical trials, aiming for increased diversity and inclusion.
What are the potential side effects?
Since this trial involves non-medical intervention (patient navigation), there are no direct medical side effects associated with drugs or treatments. However, participation could impact time and require commitment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Financial burden
Health related quality of life
Participant perceptions of the intervention (acceptability, appropriateness, feasibility)
+5 more
Secondary study objectives
Amount of money provided to participants for reimbursement of trial-related expenses
Participant time costs
Staff time and effort to deliver intervention

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ARM I (Clinical trial navigator, SOC)Experimental Treatment2 Interventions
Patients meet with a clinical trial navigator to understand activities involved with clinical trials, identify financial barriers to clinical trial participation, and review available financial resources. Patients receive ongoing access to the Guide via a check in meeting once monthly for up to 6 months. Patients also receive SOC supportive care services.
Group II: Arm II (SOC)Active Control1 Intervention
Patients receive SOC supportive care services.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Navigation
2017
Completed Phase 2
~38910

Find a Location

Who is running the clinical trial?

Fred Hutchinson Cancer CenterLead Sponsor
563 Previous Clinical Trials
1,342,311 Total Patients Enrolled
18 Trials studying Breast Cancer
21,498 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,842 Previous Clinical Trials
41,002,900 Total Patients Enrolled
945 Trials studying Breast Cancer
1,543,964 Patients Enrolled for Breast Cancer
Andy Hill Cancer Research Endowment (CARE) FundUNKNOWN
~67 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top